Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

C-Peptide Protein (full length)

Origin: Human Host: Human Synthetic > 98 % pure
Catalog No. ABIN934540
  • Target See all C-Peptide Proteins
    C-Peptide
    Protein Type
    Synthetic
    Protein Characteristics
    full length
    Origin
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Source
    • 3
    • 3
    Human
    Sequence
    Arg-Arg-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-Lys-Arg
    Characteristics
    Purified recombinant Human C Peptide protein
    Protein Source: Human (full length synthetic C-peptide) Tyr-C-Peptide
    Purification
    purified
    Purity
    > 98 % pure
    Top Product
    Discover our top product C-Peptide Protein
  • Application Notes
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    Supplied as a lyophilized powder purified by HPLC, tyrosine residue.
    Handling Advice
    Avoid repeated freeze/thaw cycles.
    Storage
    -20 °C
    Storage Comment
    Aliquot and store at -20 °C.
  • Target
    C-Peptide
    Alternative Name
    C Peptide (C-Peptide Products)
    Synonyms
    insulin 2 Protein, Ins2 Protein
    Background
    Proinsulin C-peptide was first described in 1967 in connection with the discovery of the insulin biosynthesis. It serves as an important linker between the A- and the B- chains of insulin and facilitates the efficient assembly, folding, and processing of insulin in the endoplasmic reticulum. Equimolar amounts of C-peptide and insulin are then stored in secretory granules of the pancreatic beta cells and both are eventually released to the portal circulation. Initially, the sole interest in C-peptide was as a marker of insulin secretion and has as such been of great value in furthering the understanding of the pathophysiology of type 1 and type 2 diabetes. The first documented use of the C-peptide test was in 1972. During the past decade, however, C-peptide has been found to be a bioactive peptide in its own right, with effects on microvascular blood flow and tissue health.
    Description: Human (full length synthetic C-peptide) Tyr-C-Peptide.
    Alternative Names: Proinsulin connecting peptide, C-Peptide protein
    Molecular Weight
    3616.99 kDa
You are here:
Support